Moreover, miR-181c modulates the proliferation, migration, and invasion of neuroblastoma cells by targeting Smad7, while miR-181d acts as a tumor suppressor in glioma by targeting K-ras and Bcl-2 [18,19]. This evidence concerns the gene SMAD7 and central nervous system cancer.